Clinical Trials in Bulgaria

• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 Phase III Cardiovascular Disease Amgen Inc.
• DAREON®-Lung-1: A study in people with advanced small cell lung cancer to compare obrixtamig plus atezolizumab, carboplatin, and etoposide t… Pending
  2025-520565-51-00 Phase III small cell lung cancer Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
• SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures Pending
  2025-520587-18-00 Phase II Focal Onset Seizures Supernus Pharmaceuticals Inc.
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending
  2025-521037-86-00 Phase III Immune system diseases Sanofi-Aventis Recherche & Developpement
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active ulcerative coliti… Pending
  2025-521038-27-00 Phase III Immune system diseases Sanofi-Aventis Recherche & Developpement
• A Study to Compare the Effectiveness and Safety of T1695 (0.1% Tacrolimus) Versus Ciclosporin in Participants With Moderate to Severe Vernal… Pending
  2025-521567-12-00 Phase II Vernal Keratoconjunctivitis (VKC) Laboratoires Thea
• Phase 3 trial of VMX-C001 vs usual pharmacological care in patients taking a FXa direct oral anticoagulant who require urgent surgery with o… Pending
  2025-521632-12-00 Phase III Patients on Factor Xa inhibitor treatment needing an urgent … VarmX B.V.
• An Open-Label Study of ML-007C-MA in Adults with Alzheimer’s Disease Psychosis Pending
  2025-521757-16-00 Phase II Hallucinations and Delusions Associated with Alzheimer’s Dis… Maplight Therapeutics Inc.
• ​A study to evaluate safety and explore efficacy of new lipase NHS7108 compared with pancrelipase in adult participants with exocrine pancre… Pending
  2025-521816-20-00 Phase II ​​Exocrine Pancreatic Insufficiency​ Aimmune Nestle Health Science US R&D LLC
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1) Pending
  2025-521950-41-00 Phase III severe uncontrolled asthma Generate Biomedicines Inc.
• A study to investigate how well and safe a trial drug called AZD1163, administered as an injection, works in improving symptoms and inflamma… Pending
  2025-522076-85-00 Phase II Rheumatoid arthritis AstraZeneca AB
• Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis Pending
  2025-522118-21-00 Phase IV Acute Anterior Uveitis Care Arthritis Ltd.
• (22597) A study to learn about how safe nitroglycerin is and how it affects the body when taken along with nurandociguat in people with coro… Pending
  2025-522335-34-00 Phase I (Other) Chronic kidney disease Bayer AG
• A Phase 1b/2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of IM-101 in Adult Participants with Generalized Myasthenia Gr… Pending
  2025-522406-20-00 Phase I/II Generalized Myasthenia Gravis and Ocular Myasthenia Gravis Immunabs Inc.
• A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (P… Pending
  2025-522471-28-00 Phase III psoriatic arthritis (PsA) MoonLake Immunotherapeutics AG
• LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 Pending
  2025-522475-28-00 Phase III Pulmonary Hypertension (PH) with Heart Failure with preserve… Tenax Therapeutics Inc.
• A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative co… Pending
  2025-522511-42-00 Phase II Crohn's disease Sanofi-Aventis Recherche & Developpement
• A study to test if tenecteplase helps people to recover from an acute stroke when given more than 4.5 hours after the person was last seen w… Pending
  2025-522542-40-00 Phase III Acute Ischemic Stroke Boehringer Ingelheim International GmbH
• A Phase 3, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Subjects with Active Pso… Pending
  2025-522586-30-00 Phase III Psoriatic Arthritis Takeda Development Center Americas Inc.
• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) - X-CE… Pending
  2025-522775-29-00 Phase III Depressive episodes associated with Bipolar disorder I or II… Xenon Pharmaceuticals Inc.
• Supporting weak immune system during autoimmune therapy: testing Panzyga to prevent infections Pending
  2025-522854-37-00 Phase III Prevention of a Major infection in patients with Hypogammagl… Octapharma Pharmazeutika Produktionsgesellschaft mbH
• An Open-label Study of Azetukalner in Bipolar I or II Depression Pending
  2025-522872-10-00 Phase III Depressive episodes associated with Bipolar disorder I or II… Xenon Pharmaceuticals Inc.
• A Study to Learn About the Study Medicine Called PF-08049820 in People With Eczema, an Itchy Skin Rash Pending
  2025-522965-31-00 Phase II Atopic Dermatitis Pfizer Inc.
• Treatment of adenomyosis in women of reproductive age. Pending
  2025-523076-23-00 Phase II Adenomyosis CCDRD Cooperative Clinical Drug Research and Development AG; Nadezhda Reproducti…

Showing 25–48 of 852 trials